95% CI, 0.86-0.9) and COPD (HR = 0.9
However, the degree of appetite suppression with these medications may increase the risk if diet is not structured intentionally
GLP-1 activity includes: Enhancing insulin secretion in a glucose-dependent manner Suppressing glucagon release, which would otherwise raise blood sugar Slowing gastric emptying to better regulate digestion Promoting satiety, which can reduce food intake GLP1-S in Research In laboratory research, GLP1-S is investigated for its ability to influence glucose homeostasis, appetite regulation, and energy balance
Semaglutide acts on the hypothalamus, a part of the brain that you could think of similar to a thermostat that controls more than just the body temperature
With GLP-1 medications, this may happen due to delayed gastric emptying, which allows food to remain in the stomach longer, potentially leading to bacterial fermentation and gas production with a characteristic sulphurous odour